Work ability in prostate cancer survivors after radical prostatectomy

References

• Tuomi K, Ilmarinen J, Jahkola A, Katajarinne L, Tulkki A. Work Ability Index. 2nd rev ed. Helsinki: Finnish Institute of Occupational Health; 1998.
   Google Scholar
• Tuomi K, Ilmarinen J, Seitsamo J, Huuhtanen P, Martikainen R, Nygard CH, et al. Summary of the Finnish research project (1981–1992) to promote the health and work ability of aging workers. Scand J Work Environ Health 1997;23(Suppl 1):66–71.
   PubMed Web of Science ®Google Scholar
• Alavinia SM, de Boer AG, van Duivenbooden JC, Frings-Dresen MH, Burdorf A. Determinants of work ability and its predictive value for disability. Occup Med (Lond) 2009;59:32–7.
   PubMed Web of Science ®Google Scholar
• Norwegian Cancer Registry. Nasjonalt kvalitetesregister for prostatakreft. Årsrapport 2014. 2014.
   Google Scholar
• Stensvold A, Dahl AA, Brennhovd B, Smastuen MC, Fossa SD, Lilleby W, et al. Bother problems in prostate cancer patients after curative treatment. Urol Oncol 2013;31:1067–78.
   PubMed Web of Science ®Google Scholar
• Gore JL, Gollapudi K, Bergman J, Kwan L, Krupski TL, Litwin MS. Correlates of bother following treatment for clinically localized prostate cancer. J Urol 2010;184:1309–15.
   PubMed Web of Science ®Google Scholar
• Dahl S, Loge JH, Berge V, Dahl AA, Cvancarova M, Fossa SD. Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery. J Cancer Surviv 2015;9:172–9.
   PubMed Web of Science ®Google Scholar
• Ilmarinen J, Tuomi K, Klockars M. Changes in the work ability of active employees over an 11-year period. Scand J Work Environ Health 1997;23(Suppl 1):49–57.
   PubMed Web of Science ®Google Scholar
• Steinsvik EA, Axcrona K, Dahl AA, Eri LM, Stensvold A, Fossa SD. Can sexual bother after radical prostatectomy be predicted preoperatively? Findings from a prospective national study of the relation between sexual function, activity and bother. BJU Int 2012;109:1366–74.
   PubMed Web of Science ®Google Scholar
• Brennhovd B, Axcrona K, Fossa SD, Giercksky KE, Vlatkovic L, Dahl AA. Robot-assisted radical prostatectomy of clinical high-risk patients with prostate cancer: a controlled study of operative and short-term postoperative events. Scand J Urol 2013;47:449–55.
   PubMed Web of Science ®Google Scholar
• D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280:969–74.
   PubMed Web of Science ®Google Scholar
• Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129–35.
   PubMed Web of Science ®Google Scholar
• Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899–905.
   PubMed Web of Science ®Google Scholar
• Gould R, Ilmarinen J, Järvisalo J. Dimensions of work ability. Results from the Health 2000 Survey. Helsinki: Finnish Center for Pensions; 2008.
   Google Scholar
• Taskila T, Martikainen R, Hietanen P, Lindbohm ML. Comparative study of work ability between cancer survivors and their referents. Eur J Cancer 2007;43:914–20.
   PubMed Web of Science ®Google Scholar
• Lindbohm ML, Taskila T, Kuosma E, Hietanen P, Carlsen K, Gudbergsson S, et al. Work ability of survivors of breast, prostate, and testicular cancer in Nordic countries: a NOCWO study. J Cancer Surviv 2012;6:72–81.
   PubMed Web of Science ®Google Scholar
• Torp S, Nielsen RA, Gudbergsson SB, Dahl AA. Worksite adjustments and work ability among employed cancer survivors. Support Care Cancer 2012;20:2149–56.
   PubMed Web of Science ®Google Scholar
• Gudbergsson SB, Fossa SD, Borgeraas E, Dahl AA. A comparative study of living conditions in cancer patients who have returned to work after curative treatment. Support Care Cancer 2006;14:1020–9.
   PubMed Web of Science ®Google Scholar
• Gudbergsson SB, Fossa SD, Dahl AA. Are there sex differences in the work ability of cancer survivors? Norwegian experiences from the NOCWO study. Support Care Cancer 2011;19:323–31.
   PubMed Web of Science ®Google Scholar
• Grunfeld EA, Drudge-Coates L, Rixon L, Eaton E, Cooper AF. “The only way I know how to live is to work”: a qualitative study of work following treatment for prostate cancer. Health Psychol 2013;32:75–82.
   PubMed Web of Science ®Google Scholar
• De Boer AGEM, Verbeek JHAM, Spelten ER, Uitterhoeve ALJ, Ansink A, de Reijke TM, et al. Work ability and return-to-work in cancer patients. Br J Cancer 2008;98:1342–7.
   PubMed Web of Science ®Google Scholar
• Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358:1250–61.
   PubMed Web of Science ®Google Scholar
• Kyrdalen AE, Dahl AA, Hernes E, Cvancarova M, Fossa SD. Fatigue in hormone-naive prostate cancer patients treated with radical prostatectomy or definitive radiotherapy. Prostate Cancer Prostatic Dis 2010;13:144–50.
   PubMed Web of Science ®Google Scholar
• Fransson P, Lund JA, Damber JE, Klepp O, Wiklund F, Fossa S, et al. Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial. Lancet Oncol 2009;10:370–80.
   PubMed Web of Science ®Google Scholar
• Iversen P, Mcleod DG, See WA, Morris T, Armstrong J, Wirth MP. Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years. BJU Int 2010;105:1074–81.
   PubMed Web of Science ®Google Scholar
• Oberst K, Bradley CJ, Schenk M. Breast and prostate cancer patient’s reliability of treatment reporting. J Registry Manag 2009;36:12–15.
   PubMedGoogle Scholar
• Clegg LX, Potosky AL, Harlan LC, Hankey BF, Hoffman RM, Stanford JL, et al. Comparison of self-reported initial treatment with medical records: results from the prostate cancer outcomes study. Am J Epidemiol 2001;154:582–7.
   PubMed Web of Science ®Google Scholar